NL7803289A - Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie. - Google Patents

Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie.

Info

Publication number
NL7803289A
NL7803289A NL7803289A NL7803289A NL7803289A NL 7803289 A NL7803289 A NL 7803289A NL 7803289 A NL7803289 A NL 7803289A NL 7803289 A NL7803289 A NL 7803289A NL 7803289 A NL7803289 A NL 7803289A
Authority
NL
Netherlands
Prior art keywords
insulin
peptides
inhibition
growth hormone
glucagon secretion
Prior art date
Application number
NL7803289A
Other languages
English (en)
Dutch (nl)
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of NL7803289A publication Critical patent/NL7803289A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7803289A 1977-03-28 1978-03-28 Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie. NL7803289A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/781,580 US4105603A (en) 1977-03-28 1977-03-28 Peptides which effect release of hormones

Publications (1)

Publication Number Publication Date
NL7803289A true NL7803289A (nl) 1978-10-02

Family

ID=25123228

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7803289A NL7803289A (nl) 1977-03-28 1978-03-28 Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie.

Country Status (19)

Country Link
US (1) US4105603A (enExample)
JP (1) JPS53130687A (enExample)
AT (1) AT366026B (enExample)
AU (1) AU519122B2 (enExample)
BE (1) BE865380A (enExample)
CA (1) CA1102314A (enExample)
CH (1) CH639361A5 (enExample)
DE (1) DE2813327A1 (enExample)
DK (1) DK131878A (enExample)
ES (1) ES468241A1 (enExample)
FI (1) FI780907A7 (enExample)
FR (1) FR2385688A1 (enExample)
GB (1) GB1564191A (enExample)
IE (1) IE46862B1 (enExample)
IT (1) IT1105152B (enExample)
LU (1) LU79320A1 (enExample)
NL (1) NL7803289A (enExample)
SE (1) SE446190B (enExample)
ZA (1) ZA781599B (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
USRE30548E (en) * 1979-08-31 1981-03-17 The Salk Institute For Biological Studies Peptides which effect release of hormones
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
FR2523125A1 (fr) * 1982-03-08 1983-09-16 Sanofi Sa Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
EP0400051B1 (en) * 1988-01-28 1995-05-10 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
EP1203014B1 (en) * 1999-08-06 2004-10-13 Genentech, Inc. Peptide antagonists of factor viia
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US7608681B2 (en) * 1999-12-24 2009-10-27 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
EP1757701A1 (en) 1999-12-24 2007-02-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
BRPI0414513A (pt) * 2003-09-18 2007-01-02 Raven Biotechnologies Inc kid3 e anticorpos de kid3 que se ligam a ele
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
KR101295139B1 (ko) * 2004-06-07 2013-08-12 레이븐 바이오테크놀로지스, 인코퍼레이티드 트랜스페린 리셉터 항체
JP2008515889A (ja) * 2004-10-05 2008-05-15 ジェネンテック・インコーポレーテッド 毒性の低下した治療剤
CA2593786A1 (en) 2005-01-12 2006-07-20 Raven Biotechnologies, Inc. Kid31 and antibodies that bind thereto
WO2006083852A2 (en) * 2005-01-31 2006-08-10 Raven Biotechnologies, Inc. Luca2 and antibodies that bind thereto
EP1841794B1 (en) * 2005-02-02 2013-11-20 MacroGenics West, Inc. Adam-9 modulators
US20060171952A1 (en) * 2005-02-02 2006-08-03 Mather Jennie P JAM-3 and antibodies that bind thereto
US7572896B2 (en) 2005-02-03 2009-08-11 Raven Biotechnologies, Inc. Antibodies to oncostatin M receptor
US20070197445A1 (en) * 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
JP5601836B2 (ja) * 2006-11-08 2014-10-08 マクロジェニックス ウエスト, インコーポレイテッド Tes7およびtes7に結合する抗体
US20110014287A1 (en) 2009-04-20 2011-01-20 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
GEP20166442B (en) 2010-03-04 2016-03-10 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
MY173899A (en) 2011-05-21 2020-02-26 Macrogenics Inc Cd3-binding molecules capable of binding to human and non-human cd3
CA2845886A1 (en) 2011-08-23 2013-02-28 President And Fellows Of Harvard College Peptide nanoparticles and uses thereof
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
EP3839044A1 (en) 2013-03-14 2021-06-23 MacroGenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
EP2978438A1 (en) 2013-03-29 2016-02-03 Centre National de la Recherche Scientifique (C.N.R.S.) Cgrp receptor agonist for hiv treatment or prevention
US10633440B2 (en) 2014-05-29 2020-04-28 Macrogenics, Inc. Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens
MX386297B (es) 2014-09-29 2025-03-18 Univ Duke Moleculas biespecificas que comprenden un brazo orientado a la envoltura vih-1.
CA2974807A1 (en) 2015-01-26 2016-08-04 Macrogenics, Inc. Multivalent molecules comprising dr5-binding domains
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
CR20220194A (es) 2015-07-30 2022-06-16 Macrogenics Inc Moléculas de unión a pd-1 y métodos de uso de las mismas
JP7320944B2 (ja) 2015-10-08 2023-08-04 マクロジェニクス,インコーポレーテッド B7‐h3に特異的に結合する分子及びpd‐1に特異的に結合する分子
JP7227007B2 (ja) 2015-12-02 2023-02-21 ストサイエンシス, インコーポレイテッド グリコシル化btla(b-及びt-リンパ球減弱因子)に特異的な抗体
EA201891178A1 (ru) 2015-12-14 2019-01-31 Макродженикс, Инк. Биспецифичные молекулы, обладающие иммунореактивностью в отношении pd-1 и ctla-4, и способы их применения
MX394519B (es) 2016-04-15 2025-03-24 Macrogenics Inc Moleculas de union b7-h3 novedosas, conjugados anticuerpo-farmaco de los mismos y metodos de uso de los mismos.
US10111929B1 (en) 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
KR20220088428A (ko) 2019-09-26 2022-06-27 주식회사 에스티큐브앤컴퍼니 글리코실화된 ctla-4에 대해 특이적인 항체 및 이의 사용 방법
WO2021072277A1 (en) 2019-10-09 2021-04-15 Stcube & Co. Antibodies specific to glycosylated lag3 and methods of use thereof
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations
US11951203B2 (en) 2020-08-26 2024-04-09 Chanda Zaveri Deep wrinkle vanishing compositions
US11793746B2 (en) 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
US20220110852A1 (en) 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3917578A (en) * 1973-12-10 1975-11-04 Ayerst Mckenna & Harrison Process for producing somatostatin and intermediates
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4011207A (en) * 1974-12-27 1977-03-08 American Home Products Corporation Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates

Also Published As

Publication number Publication date
ATA213878A (de) 1981-07-15
GB1564191A (en) 1980-04-02
BE865380A (fr) 1978-07-17
ZA781599B (en) 1979-10-31
AT366026B (de) 1982-03-10
JPS6141920B2 (enExample) 1986-09-18
IT7848586A0 (it) 1978-03-23
US4105603A (en) 1978-08-08
FR2385688B1 (enExample) 1983-10-07
SE446190B (sv) 1986-08-18
IT1105152B (it) 1985-10-28
FI780907A7 (fi) 1978-09-29
FR2385688A1 (fr) 1978-10-27
ES468241A1 (es) 1978-12-01
DE2813327A1 (de) 1978-10-05
IE46862B1 (en) 1983-10-19
DK131878A (da) 1978-09-29
LU79320A1 (fr) 1978-06-29
SE7803318L (sv) 1978-09-29
DE2813327C2 (enExample) 1988-08-18
CH639361A5 (de) 1983-11-15
IE780511L (en) 1978-09-28
AU3430778A (en) 1979-09-27
JPS53130687A (en) 1978-11-14
CA1102314A (en) 1981-06-02
AU519122B2 (en) 1981-11-12

Similar Documents

Publication Publication Date Title
NL7803289A (nl) Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie.
NL7901872A (nl) Wegwerp-injectiespuit.
NL7903186A (nl) Infusiepomp.
NL176229C (nl) Implanteerbare infuuspomp.
NL7801996A (nl) Chinazolineverbindingen met anti-hypertensieve werking.
NL7704980A (nl) Injectiespuit.
NL7604460A (nl) Subcutaan implanteerbare pellet.
NL182450C (nl) Wegwerpinjectiespuit.
IT7824375A0 (it) Dispositivo di pompaggio dicombustibile.
NL7601406A (nl) Injektiespuit.
NO783070L (no) Pumpeanordning.
NL7812298A (nl) Afgeeftoestel.
DK147710C (da) Fremgangsmaade til fremstilling af antifungalt aktive peptidantibiotika valgt blandt aculeacin-aalfa, aculeacin-agamma, aculeacin-dalfa og aculeac in-dgamma
NL185622C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
NL7812166A (nl) Peptiden.
NO149213C (no) Hoeytrykks-stempelpumpe.
IT7928147A0 (it) Pistone di un solo pezzo con segmento imprigionato.
ES517614A0 (es) Dispositivo para el tratamiento con disolvente de, en particular, material metalico.
NL7503724A (nl) Nieuwe peptiden met biologische werking.
NL7612502A (nl) Groeperen en groepsgewijs heffen van strobalen.
IT7830367A0 (it) Dispositivo di pompaggio dicombustibile.
NO144040C (no) Fremgangsmaate til samtidig utvinning av insulin og pankreatin av svinepankreas
IT7825904A0 (it) Siringa per iniezioni.
NL7802344A (nl) Slangenopslag- en toevoerinrichting.
DK137663B (da) Rive til behandling af på jorden liggende afgrøder, især hø.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed